ANDA 87766, held by Alpharma US Pharms. Thioridazine Hydrochloride.
As of Nov 16, 2026, ANDA 87766 (Thioridazine Hydrochloride), held by Alpharma US Pharms, was first approved by FDA on Apr 26, 1983, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 26, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thioridazine Hydrochloride30MG/ML ยท concentrate;oral | Thioridazine Hydrochloride | Discontinued |
| Sep 28, 1990 | Supplement 9Manufacturing | Approved | None posted |
| Sep 27, 1989 | Supplement 8Labeling | Approved | None posted |
| Apr 4, 1989 | Supplement 7Manufacturing | Approved | None posted |
| Sep 19, 1986 | Supplement 5Manufacturing | Approved | None posted |
| Nov 25, 1983 | Supplement 1Manufacturing | Approved | None posted |
| Apr 26, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters